EDEN Stock Overview
Develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Eden Research plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.04 |
| 52 Week High | UK£0.074 |
| 52 Week Low | UK£0.033 |
| Beta | 0.91 |
| 1 Month Change | 3.95% |
| 3 Month Change | -2.47% |
| 1 Year Change | -32.48% |
| 3 Year Change | -48.03% |
| 5 Year Change | -57.30% |
| Change since IPO | -99.37% |
Recent News & Updates
Recent updates
We Think Eden Research (LON:EDEN) Can Afford To Drive Business Growth
Aug 25
We Think Eden Research (LON:EDEN) Needs To Drive Business Growth Carefully
Jul 09We're Keeping An Eye On Eden Research's (LON:EDEN) Cash Burn Rate
Mar 05We Think Eden Research (LON:EDEN) Needs To Drive Business Growth Carefully
Nov 06Companies Like Eden Research (LON:EDEN) Are In A Position To Invest In Growth
Jul 07We're Hopeful That Eden Research (LON:EDEN) Will Use Its Cash Wisely
Feb 18
A Look At Eden Research's (LON:EDEN) Share Price Returns
Dec 25We're Hopeful That Eden Research (LON:EDEN) Will Use Its Cash Wisely
Nov 19Shareholder Returns
| EDEN | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -3.9% | -2.6% |
| 1Y | -32.5% | -25.8% | 2.7% |
Return vs Industry: EDEN underperformed the UK Chemicals industry which returned -25.8% over the past year.
Return vs Market: EDEN underperformed the UK Market which returned 2.7% over the past year.
Price Volatility
| EDEN volatility | |
|---|---|
| EDEN Average Weekly Movement | 3.9% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: EDEN has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: EDEN's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 19 | Sean Smith | www.edenresearch.com |
Eden Research plc, together with its subsidiaries, develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications under the Mevalone and Cedroz brand names. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products.
Eden Research plc Fundamentals Summary
| EDEN fundamental statistics | |
|---|---|
| Market cap | UK£20.53m |
| Earnings (TTM) | -UK£1.52m |
| Revenue (TTM) | UK£3.94m |
5.4x
P/S Ratio-13.8x
P/E RatioIs EDEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EDEN income statement (TTM) | |
|---|---|
| Revenue | UK£3.94m |
| Cost of Revenue | UK£2.01m |
| Gross Profit | UK£1.93m |
| Other Expenses | UK£3.45m |
| Earnings | -UK£1.52m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0029 |
| Gross Margin | 48.97% |
| Net Profit Margin | -38.70% |
| Debt/Equity Ratio | 0% |
How did EDEN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 18:43 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eden Research plc is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adam McCarter | Cavendish |
| Christopher Donnellan | Cavendish |
| Christopher Donnellan | Cavendish Historical (Cenkos Securities) |